Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Reprod Sci. 2012 May 30;19(12):1260–1267. doi: 10.1177/1933719112447124

Figure 1.

Figure 1

Plasma levels of MBG (a), endogenous ouabain (b), and digoxin-like immunoreactivity (c) in normotensive pregnant subjects (Ctrl) and in patients with preeclampsia (PE). d - Erythrocyte Na/K-ATPase in normal pregnant subjects and in patients with preeclampsia, and effect of ex vivo treatment with DigiFab, Digibind and 3E9 anti-MBG mAb (aMBG) on erythrocyte Na/K-ATPase. * - P<0.01 vs. PE; # - P<0.01 vs. control by repeated measures ANOVA and Newman-Keuls test.